Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
15:27:10 EDT Fri 19 Apr 2024
Enter Symbol
or Name
USA
CA



Q:VRPX - VIRPAX PHARMA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VRPX - Q0.23.68·3.872.43.68-0.23-5.95.316483.88  3.9494  3.6811.774  2.40215:02:08Mar 2615 min RT 2¢

Recent Trades - Last 10 of 48
Time ETExPriceChangeVolume
15:02:08Q3.71-0.3326
15:02:08Q3.72-0.329
15:02:08Q3.72-0.3291
14:51:57Q3.7815-0.25851
14:31:52Q3.6801-0.359910
13:19:26Q3.7409-0.29916
12:44:56Q3.7277-0.312320
12:26:13Q3.765-0.27590
12:25:53Q3.76-0.281
12:25:17Q3.68-0.23100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-26 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 Year-End Results
2024-02-27 07:31U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price
2024-02-27 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Proposed Settlement of Litigation with Sorrento Therapeutics, Inc. and Scilex Pharmaceuticals, Inc.
2024-02-07 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research
2023-12-29 07:30U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Results of Special Shareholders Meeting
2023-11-17 07:10U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Notification from Nasdaq Related to Delayed Form 10-Q Filing
2023-11-17 07:00U:VRPXNews Release ‚  Virpax Pharmaceuticals Announces Leadership Transition
2023-11-15 16:15U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 Third Quarter Results and Recent Developments
2023-10-31 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals Announces that Envelta ¢ „ ¢ Remains on Track for Trial in Humans Following FDA Review
2023-10-12 08:02U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Extension of CRADA with the U.S. Army Institute of Surgical Research
2023-10-02 08:58U:VRPXNews ReleaseGerald W. Bruce Appointed President and CEO of Novvae ¢ „ ¢ Pharmaceuticals
2023-09-27 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals Announces Results of Probudur ¢ „ ¢ Dose Escalation Studies
2023-09-26 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals to Present at the LD Micro Main Event XVI
2023-09-21 10:00U:VRPXNews ReleaseAltasciences Chosen by Virpax to Support the Development of a New Drug to Prevent Spread of Flu-like Viruses
2023-09-18 07:58U:VRPXNews ReleaseVirpax Pharmaceuticals Announces the Formation of Novvae ¢ „ ¢ Pharmaceuticals
2023-09-05 09:00U:VRPXNews ReleaseVirpax Pharmaceuticals Updates on Litigation
2023-08-28 08:58U:VRPXNews ReleaseVirpax ‚ ® Pharmaceuticals to Present at H.C. Wainwright 25th Annual Global Investment Conference
2023-08-14 09:00U:VRPXNews ReleaseVirpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments
2023-07-24 07:00U:VRPXNews ReleaseVirpax Pharmaceuticals, Inc. to Ring NASDAQ Closing Bell on July 24, 2023
2023-07-13 08:58U:VRPXNews ReleaseVirpax Pharmaceuticals Files Provisional Patent Application for Intranasal Delivery